11.78
0.03 (0.26%)
| Previous Close | 11.75 |
| Open | 11.76 |
| Volume | 21,468 |
| Avg. Volume (3M) | 49,431 |
| Market Cap | 176,506,800 |
| Price / Earnings (Forward) | 23.92 |
| Price / Sales | 1.29 |
| Price / Book | 7.54 |
| 52 Weeks Range | |
| Earnings Date | 7 Nov 2024 |
| Profit Margin | -13.95% |
| Operating Margin (TTM) | 2.02% |
| Diluted EPS (TTM) | -1.14 |
| Quarterly Revenue Growth (YOY) | 2.50% |
| Total Debt/Equity (MRQ) | 46.03% |
| Current Ratio (MRQ) | 1.44 |
| Operating Cash Flow (TTM) | 8.67 M |
| Levered Free Cash Flow (TTM) | -1.70 M |
| Return on Assets (TTM) | 2.01% |
| Return on Equity (TTM) | -60.46% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | The Joint Corp. | Bearish | Bullish |
AIStockmoo Score
| Analyst Consensus | -0.5 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | -2.5 |
| Average | -1.50 |
|
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Core |
| % Held by Insiders | 1.79% |
| % Held by Institutions | 73.25% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Douglass Winthrop Advisors, Llc | 30 Sep 2024 | 146,400 |
| Verus Capital Partners, Llc | 30 Sep 2024 | 132,955 |
| 52 Weeks Range | ||
| Median | 15.00 (27.33%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Roth MKM | 08 Nov 2024 | 15.00 (27.33%) | Buy | 11.61 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 26 Nov 2024 | Announcement | The Joint Corp. to Participate in the 13th Annual ROTH Deer Valley Event |
| 07 Nov 2024 | Announcement | The Joint Corp. Reports Third Quarter 2024 Financial Results |
| 29 Oct 2024 | Announcement | The Joint Chiropractic is Named the Official Chiropractor of Grand Canyon University Athletics |
| 24 Oct 2024 | Announcement | The Joint Corp. to Host Conference Call on Thursday, November 7th to Discuss Third Quarter 2024 Results |
| 15 Oct 2024 | Announcement | The Joint Corp. Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) |
| 14 Oct 2024 | Announcement | The Joint Corp. Appoints Sanjiv Razdan President and Chief Executive Officer |
| 10 Oct 2024 | Announcement | The Joint Chiropractic Ranks No. 150 on the Franchise Times Top 400 |
| 08 Oct 2024 | Announcement | The Joint Chiropractic Celebrates 25 Years of Making Quality Chiropractic Care Accessible |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |